1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. REAL-WORLD EVIDENCE SOLUTIONS MARKET BY COMPONENT
5.1. Introduction
5.2. Services
5.3. Data Sets
6. REAL-WORLD EVIDENCE SOLUTIONS MARKET BY APPLICATION
6.1. Introduction
6.2. Drug Development & Approvals
6.3. Medical Device Development & Approvals
6.4. Regulatory Decision Making
6.5. Others
7. REAL-WORLD EVIDENCE SOLUTIONS MARKET BY END-USER
7.1. Introduction
7.2. Healthcare Companies
7.3. Healthcare Providers
7.4. Healthcare Payers
7.5. Others
8. REAL-WORLD EVIDENCE SOLUTIONS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
10. COMPANY PROFILES
10.1. Flatiron Health (Roche Holding AG)
10.2. Ephicacy
10.3. Aetion
10.4. Evidera (PPD)
10.5. ZS
10.6. Cytel (Nordic Capital)
10.7. Certara (EQT)
10.8. Cloudbyz
10.9. Lumanity